Key facts
- BLTE - BELITE BIO, INC has 9 insiders with reported activity on this page.
- Net insider value flow over the last year: -$5,666,629.
- Recent transaction rows are available for direct filing-level review.
Insider Transactions Reported by 9 Insiders of BELITE BIO, INC
- Symbol
- BLTE on Nasdaq
- Location
- San Diego, CA
Change
- Buy value: ; sell value: $5,666,629.
- Net share flow: -33,166.
Research use
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsNet insider flow leans to selling over the last 12 months. Net value: -$5,666,629.
Buys
$0
Shares: 0
Insiders: 0
Sells
$5,666,629
Shares: 33,166
Insiders: 4
Net
-$5,666,629
Shares: -33,166
Insiders: -4
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 33,166 | $0 | $5,666,629 | -$5,666,629 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
BELITE BIO, INC executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Yu-Hsin Lin | Chief Executive Officer, Director | $60,450,859 | -$1,669,339 | -2.7% | Mixed | 21 Apr 2026 |
| Hao-Yuan Chuang | Chief Financial Officer, Director | $49,900,932 | -$1,125,303 | -2.2% | Mixed | 21 Apr 2026 |
| Hendrick Peter Scholl | Chief Medical Officer | $6,599,250 | Mixed | 21 Apr 2026 | ||
| Wan-Shan Chen | Director | $6,065,140 | -$198,473 | -3.2% | Mixed | 09 Apr 2026 |
| Nathan L. Mata | Chief Scientific Officer | $3,142,374 | -$2,673,514 | -46% | Mixed | 07 May 2026 |
| Xiao-Hui Chen | Director | Mixed | 18 Mar 2026 | |||
| John Michael Longo | Director | Mixed | 18 Mar 2026 | |||
| Ita Lu | Director | Mixed | 18 Mar 2026 | |||
| Gary Clark Biddle | Director | Mixed | 18 Mar 2026 |
Top shareholders of BELITE BIO, INC (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Lin Bioscience International Ltd. |
13D/G
|
— |
54%
|
17,095,263
|
$1,065,034,885 | $0 | 31 Dec 2024 | |
| Darwin Global Management, Ltd. |
13D/G
13F
|
Company |
8.1%
|
3,027,704
|
$479,467,205 | +$65,024,200 | 31 Dec 2025 | |
| Yu-Hsin Lin |
13D/G
3/4/5
|
Chief Executive Officer, Director |
3.1%
|
1,253,935
|
$212,905,624 | -$175,415,992 | 31 Mar 2026 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
2.8%
|
1,114,784
|
$177,741,161 | — | 31 Mar 2026 | |
| UBS Group AG |
13F
|
Company |
1.9%
|
768,359
|
$122,507,159 | — | 31 Mar 2026 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
1.8%
|
715,332
|
$114,052,534 | — | 31 Mar 2026 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.4%
|
570,088
|
$90,894,831 | — | 31 Mar 2026 | |
| Holocene Advisors, LP |
13F
|
Company |
1.2%
|
494,495
|
$78,842,283 | — | 31 Mar 2026 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.88%
|
357,650
|
$57,023,716 | — | 31 Mar 2026 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
0.75%
|
304,013
|
$48,471,833 | — | 31 Mar 2026 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.7%
|
281,805
|
$44,931,000 | — | 31 Mar 2026 | |
| MORGAN STANLEY |
13F
|
Company |
0.5%
|
201,409
|
$32,112,649 | — | 31 Mar 2026 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.38%
|
151,979
|
$24,231,532 | — | 31 Mar 2026 | |
| Patient Square Capital LP |
13F
|
Company |
0.29%
|
116,684
|
$18,604,097 | — | 31 Mar 2026 | |
| Duquesne Family Office LLC |
13F
|
Company |
0.26%
|
106,100
|
$16,917,000 | — | 31 Mar 2026 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.26%
|
105,509
|
$16,822,355 | — | 31 Mar 2026 | |
| MPM BioImpact LLC |
13F
|
Company |
0.22%
|
88,045
|
$14,037,895 | — | 31 Mar 2026 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.16%
|
65,000
|
$10,363,600 | — | 31 Mar 2026 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.15%
|
62,574
|
$9,976,799 | — | 31 Mar 2026 | |
| PFM Health Sciences, LP |
13F
|
Company |
0.15%
|
59,432
|
$9,475,838 | — | 31 Mar 2026 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.13%
|
52,000
|
$8,290,880 | — | 31 Mar 2026 | |
| Longaeva Partners L.P. |
13F
|
Company |
0.08%
|
33,492
|
$5,339,964 | — | 31 Mar 2026 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.08%
|
33,410
|
$5,326,890 | — | 31 Mar 2026 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.08%
|
32,525
|
$5,185,786 | — | 31 Mar 2026 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.07%
|
26,880
|
$4,285,747 | — | 31 Mar 2026 | |
| Artia Global Partners LP |
13F
|
Company |
0.06%
|
24,989
|
$3,984,246 | — | 31 Mar 2026 | |
| Quadrature Capital Ltd |
13F
|
Company |
0.06%
|
23,708
|
$3,780,004 | — | 31 Mar 2026 | |
| Aquatic Capital Management LLC |
13F
|
Company |
0.05%
|
20,294
|
$3,235,675 | — | 31 Mar 2026 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.05%
|
19,600
|
$3,125,024 | — | 31 Mar 2026 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.04%
|
16,981
|
$2,707,451 | — | 31 Mar 2026 | |
| STATE STREET CORP |
13F
|
Company |
0.04%
|
16,048
|
$2,558,693 | — | 31 Mar 2026 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.04%
|
15,981
|
$2,548,011 | — | 31 Mar 2026 | |
| Trexquant Investment LP |
13F
|
Company |
0.04%
|
15,072
|
$2,403,080 | — | 31 Mar 2026 | |
| XTX Topco Ltd |
13F
|
Company |
0.04%
|
15,058
|
$2,400,848 | — | 31 Mar 2026 | |
| BALANCE CAPITAL PARTNERS L.P. |
13F
|
Company |
0.04%
|
14,500
|
$2,311,880 | — | 31 Mar 2026 | |
| Verdad Advisers, LP |
13F
|
Company |
0.03%
|
13,813
|
$2,202,345 | — | 31 Mar 2026 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.03%
|
12,222
|
$1,948,676 | — | 31 Mar 2026 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.03%
|
10,922
|
$1,741,000 | — | 31 Mar 2026 | |
| Blackstone Inc. |
13F
|
Company |
0.03%
|
10,692
|
$1,704,732 | — | 31 Mar 2026 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.03%
|
10,427
|
$1,662,480 | — | 31 Mar 2026 | |
| HighVista Strategies LLC |
13F
|
Company |
0.02%
|
8,033
|
$1,280,781 | — | 31 Mar 2026 | |
| Voleon Capital Management LP |
13F
|
Company |
0.02%
|
7,883
|
$1,256,866 | — | 31 Mar 2026 | |
| BARCLAYS PLC |
13F
|
Company |
0.02%
|
6,822
|
$1,087,700 | — | 31 Mar 2026 | |
| Arrowpoint Investment Partners (Singapore) Pte. Ltd. |
13F
|
Company |
0.01%
|
6,004
|
$957,278 | — | 31 Mar 2026 | |
| Amundi |
13F
|
Individual |
0.01%
|
4,210
|
$671,242 | — | 31 Mar 2026 | |
| SmartHarvest Portfolios, LLC |
13F
|
Company |
0.01%
|
4,187
|
$667,575 | — | 31 Mar 2026 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
3,778
|
$602,365 | — | 31 Mar 2026 | |
| High Net Worth Advisory Group LLC |
13F
|
Company |
0.01%
|
3,500
|
$558,040 | — | 31 Mar 2026 | |
| Convergence Financial, LLC |
13F
|
Company |
0.01%
|
2,968
|
$473,222 | — | 31 Mar 2026 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.01%
|
2,767
|
$441,170 | — | 31 Mar 2026 |
Recent Insider Transactions by Companies or Individuals for BELITE BIO, INC
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Nathan L. Mata | BLTE | American depositary share | Sale | -100% | $102,039 | $153.21 | -666 | 0 | 07 May 2026 | Direct |
| Nathan L. Mata | BLTE | American depositary share | Sale | -60% | $153,839 | $153.84 | -1,000 | 666 | 06 May 2026 | Direct |
| Nathan L. Mata | BLTE | American depositary share | Sale | -37.5% | $155,502 | $155.50 | -1,000 | 1,666 | 05 May 2026 | Direct |
| Nathan L. Mata | BLTE | American depositary share | Sale | -27.3% | $155,636 | $155.64 | -1,000 | 2,666 | 04 May 2026 | Direct |
| Nathan L. Mata | BLTE | American depositary share | Sale | -21.4% | $155,778 | $155.78 | -1,000 | 3,666 | 01 May 2026 | Direct |
| Nathan L. Mata | BLTE | American depositary share | Sale | -17.6% | $156,973 | $156.97 | -1,000 | 4,666 | 30 Apr 2026 | Direct |
| Nathan L. Mata | BLTE | American depositary share | Sale | -15% | $155,817 | $155.82 | -1,000 | 5,666 | 29 Apr 2026 | Direct |
| Nathan L. Mata | BLTE | American depositary share | Sale | -13% | $159,162 | $159.16 | -1,000 | 6,666 | 28 Apr 2026 | Direct |
| Nathan L. Mata | BLTE | American depositary share | Sale | -11.5% | $162,641 | $162.64 | -1,000 | 7,666 | 27 Apr 2026 | Direct |
| Nathan L. Mata | BLTE | American depositary share | Sale | -10.4% | $159,556 | $159.56 | -1,000 | 8,666 | 24 Apr 2026 | Direct |
| Nathan L. Mata | BLTE | American depositary share | Sale | -9.38% | $166,284 | $166.28 | -1,000 | 9,666 | 23 Apr 2026 | Direct |
| Nathan L. Mata | BLTE | American depositary share | Sale | -8.57% | $170,384 | $170.38 | -1,000 | 10,666 | 22 Apr 2026 | Direct |
| Yu-Hsin Lin | BLTE | Ordinary Share | Other | 5.78% | 10,000 | 182,949 | 21 Apr 2026 | Direct | ||
| Hendrick Peter Scholl | BLTE | Stock Option (right to buy) | Other | 10,000 | 10,000 | 21 Apr 2026 | By Bioptima Ltd. | |||
| Hao-Yuan Chuang | BLTE | Ordinary Share | Other | 5.12% | 10,000 | 205,264 | 21 Apr 2026 | Direct | ||
| Nathan L. Mata | BLTE | American depositary share | Sale | -7.9% | $166,000 | $166.00 | -1,000 | 11,666 | 21 Apr 2026 | Direct |
| Nathan L. Mata | BLTE | American depositary share | Sale | -7.32% | $163,595 | $163.59 | -1,000 | 12,666 | 20 Apr 2026 | Direct |
| Nathan L. Mata | BLTE | American depositary share | Sale | -6.82% | $161,630 | $161.63 | -1,000 | 13,666 | 17 Apr 2026 | Direct |
| Nathan L. Mata | BLTE | American depositary share | Sale | -6.38% | $160,381 | $160.38 | -1,000 | 14,666 | 16 Apr 2026 | Direct |
| Nathan L. Mata | BLTE | American depositary share | Sale | -6% | $168,298 | $168.30 | -1,000 | 15,666 | 15 Apr 2026 | Direct |
| Yu-Hsin Lin | BLTE | American depositary share | Sale | -5.11% | $1,669,339 | $181.45 | -9,200 | 170,934 | 09 Apr 2026 | Direct |
| Wan-Shan Chen | BLTE | American depositary share | Sale | -10.8% | $198,473 | $180.43 | -1,100 | 9,096 | 09 Apr 2026 | Direct |
| Hao-Yuan Chuang | BLTE | American depositary share | Sale | -6.2% | $1,125,303 | $181.50 | -6,200 | 93,800 | 09 Apr 2026 | Direct |
| Wan-Shan Chen | BLTE | Stock Option (right to buy) | Award | 13,796 | 13,796 | 31 Mar 2026 | Direct | |||
| Hao-Yuan Chuang | BLTE | Stock Option (right to buy) | Award | 100% | 144,868 | 289,736 | 31 Mar 2026 | Direct | ||
| Nathan L. Mata | BLTE | Stock Option (right to buy) | Award | 117.7% | 144,868 | 267,934 | 31 Mar 2026 | Direct | ||
| Yu-Hsin Lin | BLTE | Stock Option (right to buy) | Award | 100% | 206,954 | 413,908 | 31 Mar 2026 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.